An Unusual Presentation of Granulomatosis With Polyangiitis (Wegener's) After SARS-CoV-2 Infection.

anca associated vasculitis covid-19 related issues differential diagnosi granulomatosis with polyangiitis (gpa) pulmonary cavitary lesion unusual case wegener’s granulomatosis

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Dec 2023
Historique:
accepted: 05 12 2023
medline: 8 1 2024
pubmed: 8 1 2024
entrez: 8 1 2024
Statut: epublish

Résumé

In this article, we present an unusual case of granulomatosis with polyangiitis (GPA) in a 41-year-old man. The initial presentation of the disease was atypical, with persistent fever, cough, and fatigue, accompanied by elevated inflammatory markers in association with a large, solitary lung lesion observed at the chest X-ray. Despite the presence of an initial radiological picture suggesting pneumonia, the lack of response to antibiotics necessitated a more in-depth evaluation. The diagnosis was confirmed through a lung biopsy and serological tests positive for anti-neutrophil cytoplasmic antibodies (c-ANCA). GPA is an anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, a systemic autoimmune disease characterized by necrotizing granulomatous inflammation and pauci-immune small vessel vasculitis. This case posed diagnostic challenges due to the atypical presentation, initially mistaken for a respiratory tract infection versus cancer. However, the lack of improvement with antibiotics and persistent inflammation raised suspicions of an underlying complex condition. The diagnosis was confirmed through a lung biopsy and positive c-ANCA serological tests. The patient had reported a prior SARS-CoV-2 infection, raising questions about the possible connection between COVID-19 and GPA, as suggested by previous studies. The diagnostic workup ruled out common and rare pulmonary infections, autoimmune diseases, and neoplasms. However, the presence of positive c-ANCA antibodies was pivotal for the GPA diagnosis. Treatment involved the use of high-dose corticosteroids and rituximab to suppress the autoimmune response. Early diagnosis and timely treatment are essential for improving outcomes in patients with GPA.

Identifiants

pubmed: 38186427
doi: 10.7759/cureus.50088
pmc: PMC10770579
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e50088

Informations de copyright

Copyright © 2023, Romanello et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Daniele Romanello (D)

Internal Medicine, Ospedale San Pietro Fatebenefratelli, Rome, ITA.

Marta Giacomelli (M)

Internal Medicine, University of Rome "Campus Bio-Medico", Rome, ITA.

Ilaria Coccia (I)

Internal Medicine, University of Rome Tor Vergata, Rome, ITA.

Paolo Lido (P)

Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, ITA.

Sara Rotunno (S)

Internal Medicine, Ospedale San Pietro Fatebenefratelli, Rome, ITA.

Classifications MeSH